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Epidermal water barrier defect
Epidermal calcium gradient
Epidermal ceramidesThe keratitis–ichthyosis–deafness (KID) syndrome is caused by mutations in the gap junctional
channel protein connexin 26 (Cx26), among them the mutation Cx26S17F. Heterozygous Cx26S17F
mice resemble the human KID syndrome, i.e. exhibiting epidermal hyperplasia and hearing impair-
ments. Newborn Cx26S17F mice show a defective epidermal water barrier as well as altered epider-
mal lipid secretion and location. Linoleoylx-esteriﬁed ceramides are strongly decreased on the skin
surface of Cx26S17F mice. Moreover, the epidermal calcium gradient is altered in the mutant mice.
These alterations may be caused by an abnormal Cx26S17F channel function that leads to a defective
epidermal water barrier, which in turn may trigger the hyperproliferation seen in the KID
syndrome.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The keratitis–ichthyosis–deafness (KID) syndrome (OMIM
#148210) is a rare autosomal-dominant hereditary disease, affect-
ing the skin, the cochlea and the eyes of patients. Skin defects in
the KID syndrome include thickening of all epidermal layers, pal-
moplantar hyperkeratosis and hyperkeratotic plaques. Moreover,
KID patients suffer from prelingual sensorineural hearing loss
(SNHL) and chronic inﬂammation of the eye’s cornea [1].
The main function of the multilayered epidermis is to maintain
a barrier which prevents water, bacteria and toxin penetration as
well as water loss from the body. This epidermal barrier is mainly
established by the corniﬁed envelope and the extracellular lipid
lamellae of the stratum corneum [2]. Besides free fatty acids,
cholesterol and cholesterol esters, the main component of theextracellular lipid lamellae of the stratum corneum are ceramides,
which show a large diversity in their acyl residues as well as in the
degree of saturation of their long chain base residues [3,4]. These
ceramides are synthesized during epidermal differentiation in the
stratum granulosum and packed into membrane enclosed lamellar
bodies. After secretion at the interface between stratum granulo-
sum and stratum corneum they surround the corneocytes of the
stratum corneum, constituting the major portion of the extracellu-
lar lipid lamellae.
An epidermal calcium gradient is known to regulate the epider-
mal differentiation as well as lipid secretion and is therefore a pre-
requisite for an intact epidermal barrier [5]. In healthy skin there is
a relatively low amount of calcium ions in the stratum basale.
During differentiation the calcium concentration rises and peaks
in the stratum granulosum. During the last differentiation step
the calcium ions are removed intra- and extracellularly from the
stratum corneum [6–8].
Connexins are the transmembrane protein subunits of gap junc-
tion channels which mediate the exchange of ions and small mole-
cules up to a mass of 1.8kDa [9]. As members of a multigene family,
21 different connexin isoforms are known to be expressed in
humans, while 20 connexin isoforms have been described in mice
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hemichannel, which can interact with a hemichannel of a contact-
ing cell to form an intercellular gap junction channel [11].
Connexin hemichannels can be involved in paracrine and autocrine
signaling by connecting the cytoplasm to the extracellular environ-
ment and facilitating the diffusional exchange of molecules and
ions such as IP3, ATP and calcium [12].
Several mutations in the human Cx26 gene GJB2 have been
associated with the KID syndrome. One of them leads to the
exchange of a serine residue by a phenylalanine residue at position
17 of the Cx26 amino acid sequence (Cx26S17F), located near the
N-terminus of the Cx26 protein [13]. Expression and dye transfer
analyses of the mutated Cx26S17F protein in HeLa cells and
Xenopus oocytes showed that the Cx26S17F protein can be trans-
ported to the plasma membrane but forms coupling deﬁcient gap
junction channels and inactive homotypic hemichannels [13,14].
However, a recent study suggests that if Cx26S17F is
co-expressed with wild type Cx26 or Cx43 in transfected HeLa
cells, the hemichannel activity is increased compared to homo-
meric wild type hemichannels [15]. These results with heteromeric
Cx26S17F/Cx26wt channels are more likely to represent the situa-
tion in patients suffering from the autosomal dominant KID
syndrome.
Previously we have described the Cx26S17F mouse mutant
which resembles the KID syndrome in many aspects.
Heterozygous Cx26S17F+/ﬂox: PGK-Cre mice (here referred to as
‘‘Cx26S17F mice’’) showed a dry, scaly skin. Adult Cx26S17F mice
exhibited epidermal hyperproliferation and strong hyperplasia of
all epidermal layers. Furthermore, the hearing of Cx26S17F mice
was impaired [16].
In order to explain the skin phenotype of Cx26S17F mice and
KID patients, here we have further characterized the epidermis of
newborn Cx26S17F mice by analyzing the distribution, secretion
and composition of epidermal lipids as well as of the distribution
of the epidermal calcium gradient.2. Materials and methods
2.1. Treatment of mice
All experiments were performed with littermates of >87.5%
BL/6N genetic background.
All mice used in this study were kept under standard housing
conditions with a 12 h/12 h dark–light cycle with food and water
ad libitum. All experiments were carried out in agreement with
local and state regulations for research with animals.
2.2. Generation/breeding of mice
The generation of the conditional Cx26S17F mouse was
described in detail by Schütz et al. [16]. Female
Cx26S17Fﬂox/ﬂox mice were bred with male phosphoglycerate
kinase (PGK)-Cre recombinase expressing mice leading to
exchange of wild type Cx26 by Cx26S17F in every cell type endoge-
nously expressing Cx26. In this study Cx26S17F+/ﬂox mice are
referred to as ‘‘control mice’’, whereas Cx26S17F+/ﬂox: PGK-Cre
mice are referred to as ‘‘Cx26S17F mice’’.
2.3. Nile red staining
For Nile Red stainings, paw cryosections were ﬁxed in 4%
paraformaldehyde, incubated for 2 h with 5 lg/mL Nile Red solu-
tion (Sigma–Aldrich, Cat. No. 72485, St. Louis, MO, USA) and
mounted with Glycergel mounting medium (DakoCytomation,
Glostrup, Denmark).2.4. Electron microscopy and ion-capture cytochemistry
The skin biopsies were ﬁxed in modiﬁed Karnovsky ﬁxative (2%
formaldehyde and 2% glutaraldehyde in 0.1 M cacodylate buffer,
pH 7.2) and post-ﬁxed in either 0.2% RuO4 or 1% OsO4 [17]. For
ion-capture cytochemistry the samples were ﬁxed in ice-cold ﬁxa-
tive containing 2% glutaraldehyde, 2% formaldehyde, 90 mM potas-
sium oxalate, and 1.4% sucrose (pH 7.4) in the dark for 1–2 h [6].
The samples were then postﬁxed in 1% OsO4 containing 2% potas-
sium pyroantimonate at 4 C in the dark for 2 h. All samples were
then dehydrated and embedded in Epoxy resin [6]. Ultrathin sec-
tions stained with 1% uranyl acetate and 0.4% lead citrate were
examined in either a JEOL (Jeol Ltd., Japan) or in a Zeiss EM9-02
(Zeiss, Germany) transmission electron microscope.
2.5. Lipid extractions
For extraction of epidermal lipids, skin and paw skin was incu-
bated with Dispase II (2 U/mL in PBS, Sigma–Aldrich, St. Louis, MO,
USA) overnight at 4 C. After washing with PBS the epidermis could
be separated from the dermis. The epidermis was homogenized in
water using a Precellys tissue homogenizer (PEQLAB, Erlangen,
Germany) and lyophilized. Epidermal lipids were extracted for
24 h at 37 C in each of three solvent mixtures: chloro-
form/methanol/water 1:2:0.5 (v/v/v); chloroform/methanol 1:1
(v/v), and chloroform/methanol 2:1 (v/v). The ﬁnal supernatant
was used for mass spectrometry analyses.
Surface lipids were extracted using a protocol described previ-
ously [18], modiﬁed as follows: Newborn (P0) mice were sacriﬁced
by inhalation of isoﬂurane. To release epidermal lipids whole mice
were covered in n-hexane/ethanol 2:1 (v/v) for 10 min. The organic
solvent was evaporated under a stream of nitrogen at 50 C and
lipids were extracted in chloroform/methanol/water 2:1:0.8
(v/v/v) followed by soniﬁcation for 5 min. Then chloroform and
water were added to the ﬁnal ratio of chloroform/methanol/water
2:2:1.8 (v/v/v), vortexed and centrifuged for phase separation. The
lower lipid-containing chloroform phase was collected and evapo-
rated under a stream of nitrogen.
2.6. Mass spectrometry analyses
Relative amounts of epidermal ceramides of Cx26S17F mice
compared to wild type mice were quantiﬁed using the Agilent
6530 Accurate-Mass Q-TOF LC/MS instrument equipped with a
direct infusion chip-based nanospray ion source. The nanospray
solvent was chloroform/methanol/300 mm ammonium acetate
(300:665:35) [19]. Sphingolipids were ionized in the positive
mode. Instrumental parameters were set as described previously
[20]. Cer[EOS], Cer[AS] and Cer[NS] were quantiﬁed using precur-
sor ion scanning for a characteristic fragment, m/z 264.2686, gen-
erated after collision-induced dissociation and normalized to the
internal standard d18:1–12:0 ceramide (Avanti Polar Lipids).
Data are represented as mol% of total sphingolipids detected.
2.7. Immunoblot analyses
Total proteins were extracted from skin using a Precellys tissue
homogenizer (PEQLAB, Erlangen, Germany) in lysis buffer
(2  Complete [Roche, Mannheim, Germany], 1% Triton X-100,
0.5% Nonidet P40, 50 mM NaCl, 30 mM Na4P2O710  H2O, 1 mM
Na3VO4, 50 mM NaF, 1 mM PMSF, 20 mM HEPES) 4 times for 20 s
and centrifuged at 6800g. Laemmli buffer [21] was added to pro-
tein lysates and 50 lg proteins were separated by electrophoresis
in 12% sodium dodecyl sulfate polyacrylamide gels. Then the pro-
teins were transferred to a Hybond ECL membrane (Amersham
Biosciences, Buck, UK) and blocked with 5% milk powder in TBST
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temperature. The membranes were incubated with primary mouse
anti-PCNA antibodies (diluted 1:250, Santa Cruz Biotechnology,
Dallas, TX, USA; Cat. No. sc-25280) overnight at 4 C. After incuba-
tion with primary antibodies the membranes were washed 3 times
with TBST at room temperature and incubated for 1 h with horse-
radish peroxidase-conjugated secondary antibodies (goat
anti-mouse, diluted 1:10000, Jackson ImmunoResearch, West
Grove, PA, USA). For detection the membranes were incubated
with enhanced chemiluminescence reagents (Pierce, Rockford, IL,
USA). Loading controls were performed with mouse anti-tubulin
antibodies (diluted 1:20000, Sigma–Aldrich, St. Louis, MO, USA
Cat. No. T9026).
2.8. Immunoﬂuorescence analyses
For immunoﬂuorescence analyses skin biopsies were frozen in
Tissue-Tek embedding medium (Sakura, Zoeterwonde,
Netherlands). 14 lm cryosections were ﬁxed in 4% paraformalde-
hyde for 5 min, washed 3 times in TBS-TX (50 mM Tris,1.5% NaCl,
0.3% TritonX-100) and blocked for 1 h with 4% bovine serum albu-
min and 1% normal goat serum in TBS-TX. Primary rat anti-Ki67
antibody (monoclonal, diluted 1:50, DakoCytomation, Glostrup
Denmark, Cat. No. M7249) was diluted in blocking solution and
incubated with cryosection over night at 4 C. Afterwards the sec-
tions were washed 3 times with TBS-TX and incubated with sec-
ondary antibodies Alexa Fluor 546 goat anti-rat IgG (diluted
1:1000, Invitrogen, Cat. No. A-11081, USA) for 45 min. Then the
stained sections were washed 3 times with TBS-TX, embedded in
Glycergel mounting medium (DakoCytomation), and analyzed by
confocal microscopy (Zeiss, LSM 710, Germany).
2.9. Statistical analyses
Two-tailed Student’s t-tests were used for statistical analyses. A
P-value of <0.05 was regarded as statistically signiﬁcant. Asterisks
indicate a P-value of <0.05 (*), <0.01 (**) or <0.001 (***). Error bars
represent standard error of the mean (S.E.M.).3. Results
3.1. Disarrangement of lipids in the stratum corneum
Previous analyses using toluidine blue staining on newborn
Cx26S17F mice indicated a water barrier defect in the mutated
mice [16]. Additional experiments with X-gal dye penetration
revealed that the water barrier was disrupted already during late
embryonic development on embryonic day 21.5 (data not shown).
To deﬁne the basis for the observed water barrier defect, the
epidermal lipid distribution was analysed by lipid stainings of skin
cryosections and by electron microscopy (EM) analyses. Staining
with the ﬂuorescent lipid dye Nile red on paw cryosections showed
that in newborn and in adult Cx26S17F mice lipids accumulated in
a dot-like pattern in the stratum corneumwhile in control mice the
lipids were evenly distributed in extracellular lipid lamellae
(Fig. 1A–H). Note the strong hyperkeratosis in adult mice repre-
sented by the severe thickening of the stratum corneum (Fig. 1C,
G), while newborn Cx26S17F mice did not show hyperkeratosis
compared to control mice (Fig. 1A, E). Marked hyperproliferation
was evident in adult Cx26S17F mice while in newborn Cx26S17F
mice no hyperproliferation was observed with the proliferation
markers Ki67 and PCNA (Supplemental Fig. 1 and Schütz et al.
[16]) indicating that hyperproliferation and hyperkeratosis devel-
oped during ageing.To further study the abnormal lipid organisation, electron
microscopic (EM) analyses on ultrathin paw sections of newborn
mice were performed. They showed lipid inclusions inside the cor-
neocytes of Cx26S17F epidermis that were not present in stratum
corneum of controls (Fig. 1I and J). These inclusions are likely to
represent the lipid dots seen in the Nile red staining suggesting
that at least some lipids are mislocated inside the corneocytes in
Cx26S17F epidermis instead of surrounding the corneocytes seen
in control epidermis. Additionally, EM analyses showed that the
stratum corneum of Cx26S17F epidermis was much more compact
than in controls and that aggregates of non-processed keratohyalin
were still present in Cx26S17F stratum corneum (Fig. 1I and J).
3.2. Premature secretion of lipids
To characterize the epidermal lipid secretion via lamellar body
release, EM analysis was performed on epidermal back skin sec-
tions of newborn mice. In control mice the secretion of lipids
was observed at the stratum granulosum/stratum corneum
(SC/SG) interface (Fig. 2A, white arrowheads), while in the
Cx26S17F epidermis additional premature secretion was seen in
the stratum granulosum (Fig. 2B, black arrowheads).
3.3. Loss of linoleoyl x-esteriﬁed ceramides (Cer[EOS]) at the
epidermal surface
In addition to the analyses of lipid distribution and secretion the
ceramide composition was analysed in the epidermis by mass
spectrometry. Two lipid extraction methods were used. In the ﬁrst
method the lipids of the intact epidermal surface of control and
Cx26S17F mice were extracted by immersing newborn mice in
organic solvent. In the second method the whole epidermis was
lysed prior to extraction leading to recovery of ceramides from
all epidermal layers.
These analyses revealed that the relative amount of the
barrier-essential Cer[EOS] with fatty acid residues ranging from
h30:0 to h36:0 were strongly decreased on the epidermal surface
of Cx26S17F epidermis compared to control samples (Fig. 3A). In
contrast, after extraction of whole epidermis, only minor differ-
ences in the relative amounts of Cer[EOS] in Cx26S17F mice were
found compared to control mice (Fig. 3B). This indicates that
Cer[EOS] can be synthesized but are not correctly released to the
epidermal surface of Cx26S17F mice. Additionally, alterations in
other ceramide classes could be observed, e.g. an increase of the
relative amount of Cer[NS] (see proﬁle of Cer[AS] and Cer[NS] in
Supplemental Figs. 2 and 3).
3.4. Disturbed formation of the epidermal calcium gradient
Since the stepwise conversion of keratinocytes into corneocytes
and the establishment of the epidermal barrier depend on a epider-
mal calcium gradient, we visualized the calcium gradient in
Cx26S17F epidermis using ion-capture cytochemistry. In control
epidermis the stratum granulosum contained a high number of cal-
cium precipitates, while the stratum corneum was completely cal-
cium free (Fig. 4A). In contrast, in the Cx26S17F epidermis large
amounts of calcium intra- and extracellular of the stratum cor-
neum as well as in the stratum corneum/stratum granulosum junc-
tion were found (Fig. 4B). This indicates that the Cx26S17F
mutation leads to a disturbed calcium gradient.
4. Discussion
In this study the skin phenotype of the previously generated
KID syndrome mouse model Cx26S17F was further investigated
Fig. 1. Lipid distribution in the epidermis. (A–D) Nile red stainings of paw epidermis of newborn (A, B) and adult (C, D) control mice. Examples of the evenly distributed lipid
lamellae of the stratum corneum are indicated by arrows in B and D. (E–H) In newborn (E, F) and adult (G, H) Cx26S17F mice the lipids accumulate in a dot-like pattern in the
stratum corneum (arrows). The stratum corneum of adult mice is strongly thickened leading to ﬁelds of ‘‘lipid-dots’’ (surrounded by a dashed line in H). SC: stratum corneum.
Scale bars: 20 lm. (I–J) Electron micrographs of stratum corneum of paws. (I) The stratum corneum of control mice shows lipid lamellae in between the corneocytes (arrows).
(J) In Cx26S17F mice the stratum corneum appears more compact than control stratum corneum. There are lipid inclusions inside the corneocytes (arrows). Additionally,
aggregates of non-processed keratohyalin can be observed (asterisk). Scale bars: 1 lm.
Fig. 2. Epidermal lipid secretion. (A) Fusion of the lamellar bodies of control mice takes place at the SG/SC junction (white arrowheads). (B) In Cx26S17F mice an additional
premature lipid secretion was observed in the SG (black arrowheads). SC: stratum corneum; SG: stratum granulosum. Scale bars: 2 lm.
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as well as the distribution of the epidermal calcium gradient.It was previously shown that the skin phenotype of adult
Cx26S27F mice (i.e. thickening and hyperkeratosis of the epider-
Fig. 3. Mass spectrometric analyses of Cer[EOS]. (A) Cer[EOS] with fatty acid residues ranging from h30:0-18:2 to h36:0-18:2 on epidermal surface. The relative amount of
Cer[EOS] (in mol% of all ceramides) is strongly diminished on the epidermal surface of Cx26S17F mice. n = 3. (B) Cer[EOS] composition (mol% of all ceramides) in lipid extracts
from whole epidermis. Relative amounts of Cer[EOS] are only slightly decreased when extracted from all epidermal layers. n = 4. Cer: ceramide; E: esteriﬁed with linoleic
acid; O: x-hydroxylated fatty acid; S: sphingosine long chain base.
Fig. 4. Ioncapture cytochemistry of epidermal calcium. (A) In control mice SG keratinocytes contains many calcium precipitates (arrows), while the extracellular SG/SC
junction as well as the SC corneocyte are completely free of calcium. (B) In the Cx26S17F mutant large amounts of calcium are retained in the SC as well as in the extracellular
SG/SC junction (arrows). SG: stratum granulosum; SC: stratum corneum; scale bar: 1 lm.
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expressed already during embryonic development of the skin
[22], the epidermis of newborn Cx26S17F mice is not hyperprolif-
erative (Supplemental Fig. 1). This indicates that the Cx26S17F
mutation does not directly inﬂuence the proliferation rate of the
epidermis during its development, but rather triggers the hyper-
proliferation indirectly after birth.
This trigger is likely to be the observed epidermal barrier defect
which occurs already during embryonic development. It had been
shown that DNA synthesis in the basal layer can be activated by
barrier disruption [23]. Therefore, it is likely that the hyperprolifer-
ation in Cx26S17F mice and presumably also in KID patients is a
stress response to an initial barrier defect.
The observed barrier defect can be attributed to the altered epi-
dermal lipid properties of the Cx26S17F mice. Our results show
lipid residues inside the corneocytes of the stratum corneum as
well as premature secretion of lipids in stratum granulosum of
Cx26S17F mice (Figs. 1 and 2). Interestingly, similar lipid residues
inside corneocytes were found in a ceramide synthase 3 (CerS3)
knock-out mouse line. Because of the lack of the CerS3 enzyme,
the epidermis of CerS3 null mutants harbors no esteriﬁed cera-
mides with ultralong fatty acid residues (Cer[EOS]) [24]. Here we
analyzed the ceramide composition of both the epidermis andthe epidermal surface. We found that the barrier essential
Cer[EOS] can be detected in samples containing whole epidermal
lysates but are strongly decreased on the skin surface (Fig. 3).
This indicates that Cer[EOS] can be synthesized in the epidermis,
but do not correctly reach the epidermal surface, supporting the
observations of premature lamellar body secretion and lipid resi-
dues inside the corneocytes.
The stepwise differentiation of the basal keratinocytes into ter-
minally differentiated corneocytes accompanied by the establish-
ment of the epidermal barrier is dependent on a speciﬁc amount
of extra- and intracellular calcium [5]. In this study the epidermal
calcium gradient was analyzed in Cx26S17F mice by ion-capture
cytochemistry revealing large amounts of calcium in the normally
calcium free stratum corneum (Fig. 4).
It has previously been shown that epidermal permeability and
calcium barrier formation are mutually dependent on each other,
as indicated by the fact that the appearance of the calcium gradient
and the formation of the epidermal barrier occurs simultaneously
during embryonic development [25]. In this study we have shown
that in the Cx26S17F mouse line both the epidermal water barrier
and the calcium gradient were disturbed. The Cx26S17F mutation
may induce an imbalance of the epidermal calcium homoeostasis,
either by leading to a closure of gap junction channels and
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gests – by hyperactivation of heteromeric hemichannels [15] (gain
of function). This disturbance of epidermal calcium homeostasis
could lead to an impaired lipid processing, which in turn may trig-
ger the observed barrier impairment. It has been suggested that
the fusion of the barrier lipids containing lamellar bodies is cal-
cium dependent [25,26]. Moreover, enzymes important for barrier
formation are described to be activated by calcium. For example
transglutaminase 1, which catalyzes the binding of Cer[EOS] to
proteins of the corniﬁed envelope calcium dependently [27].
However, the diffusion of calcium ions into stratum corneum
can be generally observed in barrier compromised skin [28].
Therefore, an alternative order of events appears to be possible
in which the water barrier is disturbed prior to the changes in
the calcium distribution.
One other KID syndrome mouse model has been published har-
boring the Cx26G45E mutation [29]. The inducible Cx26G45E
mouse line develops a severe KID phenotype, e.g. a severe hyperk-
eratosis and scaling of the epidermis. The molecular basis leading
to the observed hyperkeratosis could the same in both mouse lines.
Therefore it would be interesting to analyze the lipid composition
and calcium gradient in other KID mouse lines. Furthermore, it
would be beneﬁcial to analyze the epidermal barrier and surface
ceramide composition in future case studies with KID patients.
Besides hyperkeratosis KID patients are prone to chronic bacte-
rial and fungal skin infections [30–32]. It was shown that Cx26
hemichannels harboring KID mutations are activated by the
pro-inﬂammatory mediator peptidoglycan [33]. A lowering of the
epidermal barrier due to a disturbed lipid composition may
enhance the susceptibility to infections in KID patients.
In summary, our study further characterizes the role of Cx26 in
epidermal barrier acquisition and suggests that the skin phenotype
of Cx26S17F mice may be a stress response to an initial water bar-
rier defect. The development of epidermal hyperkeratosis may fol-
low a similar pathway in KID patients as in Cx26S17F mice.
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